Targeting cancer with nano-bullets: Curcumin, EGCG, resveratrol and quercetin on flying carpets

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 9, 2014, Pages 3865-3871

  Aras, Aliye ^a   Khokhar, Abdur Rehman ^b   Qureshi, Muhammad Zahid ^c   Silva, Marcela Fernandes ^d   Sobczak Kupiec, Agnieszka ^e   Pineda, Edgardo Alfonso Gómez ^d   Hechenleitner, Ana Adelina Winkler ^d   Farooqi, Ammad Ahmad ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b RLMC   (Pakistan)

^c GCU   (Pakistan)

^d STATE UNIVERSITY OF MARINGÁ   (Brazil)

^e CRACOW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Apoptosis; EGCG; Nanotechnology; Resveratrol

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; CATECHIN; CURCUMIN; DRUG CARRIER; EPIGALLOCATECHIN GALLATE; LACTIC ACID; NANOPARTICLE; PLANT MEDICINAL PRODUCT; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; POLYMACON; QUERCETIN; RESVERATROL; SILICON DIOXIDE; STILBENE DERIVATIVE;

ANALOGS AND DERIVATIVES; ANIMAL; APOPTOSIS; CELL PROLIFERATION; CELL TRANSFORMATION; CHEMISTRY; DRUG EFFECTS; DRUG SCREENING; HUMAN; MOUSE; NEOPLASMS;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; APOPTOSIS; CATECHIN; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CURCUMIN; DRUG CARRIERS; HUMANS; LACTIC ACID; MICE; NANOPARTICLES; NEOPLASMS; PHYTOCHEMICALS; POLYGLYCOLIC ACID; POLYHYDROXYETHYL METHACRYLATE; QUERCETIN; SILICON DIOXIDE; STILBENES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84902670084     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.9.3865     Document Type: Short Survey

References (88)

1. Ahmed SR, Dong J, Yui M, et al (2013). Quantum dots incorporated magnetic nanoparticles for imaging colon carcinoma cells. J Nanobiotechnol, 11, 28.
2. Alexis F, Pridgen EM, Langer R, Farokhzad OC (2010). Nanoparticle technologies for cancer therapy. Journal, 55-86.
3. Allan B (1999). Closer to nature: new biomaterials and tissue engineering in ophthalmology. Br J Ophthalmol, 83, 1235-40.
4. Alotaibi A, Bhatnagar P, Najafzadeh M, Gupta KC, Anderson D (2013). Tea phenols in bulk and nanoparticle form modify DNA damage in human lymphocytes from colon cancer patients and healthy individuals treated in vitro with platinum-based chemotherapeutic drugs. Nanomedicine, 8, 389-401.
5. Asghar W, Islam M, Wadajkar AS, et al (2012). PLGA micro-and nanoparticles loaded into gelatin scaffold for controlled drug release. Nanotechnology, IEEE Transactions on, 11, 546-53.
6. Bu L, Gan L-C, Guo X-Q, et al (2013). Trans-resveratrol loaded chitosan nanoparticles modified with biotin and avidin to target hepatic carcinoma. Int J Pharm, 452, 355-62.
7. Campolongo MJ,Luo D (2009). Drug delivery: old polymer learns new tracts. Nature materials, 8, 447-8.
8. Chang P-Y, Peng S-F, Lee C-Y, et al (2013). Curcumin-loaded nanoparticles induce apoptotic cell death through regulation of the function of MDR1 and reactive oxygen species in cisplatin-resistant CAR human oral cancer cells. Int J Oncol, 43, 1141-50.
9. Chen J, Dai W, He Z, et al (2013). Fabrication and evaluation of curcumin-loaded nanoparticles based on solid lipid as a new type of colloidal drug delivery system. Indian J Pharmaceutical Sci, 75, 178.
10. Chouhan R,Bajpai A (2009). An in vitro release study of 5-fluoro-uracil (5-FU) from swellable poly-(2-hydroxyethyl methacrylate)(PHEMA) nanoparticles. J Mater Sci Mater Med, 20, 1103-14.
11. Coelho JF, Ferreira PC, Alves P, et al (2010). Drug delivery systems: Advanced technologies potentially applicable in personalized treatments. EPMA J, 1, 164-209.
12. Cruz LJ, Tacken PJ, Fokkink R, et al (2010). Targeted PLGA nano-but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro. J Control Release, 144, 118-26.
13. Dai X, Yin H, Sun L, et al (2013). Potential therapeutic efficacy of curcumin in liver cancer. Asian Pac J Cancer Prev, 14, 3855-9.
14. Danhier F, Ansorena E, Silva JM, et al (2012). PLGA-based nanoparticles: An overview of biomedical applications. J Control Release, 161, 505-22.
15. Dilnawaz F,Sahoo SK (2013). Enhanced accumulation of curcumin and temozolomide loaded magnetic nanoparticles executes profound cytotoxic effect in glioblastoma spheroid model. Eur J Pharm Biopharm, 85, 452-62.
16. Dobic SN, Filipovic JM, Tomic SL (2012). Synthesis and characterization of poly (2-hydroxyethyl methacrylate/itaconic acid/poly (ethylene glycol) dimethacrylate) hydrogels. Chemical Engineering Journal, 179, 372-80.
17. Dora CL, Silva L, Putaux J-L, et al (2012). Poly (ethylene glycol) hydroxystearate-based nanosized emulsions: effect of surfactant concentration on their formation and ability to solubilize quercetin. J Biomed Nanotechnol, 8, 202-10.
18. Fan G-H, Wang Z-M, Yang, et al (2014). Resveratrol inhibits oesophageal adenocarcinoma cell proliferation via AMP-activated protein kinase signaling. Asian Pac J Cancer Prev, 15, 677-82.
19. Fang J-Y, Li Z-H, Li Q, et al (2012). Resveratrol affects protein kinase C activity and promotes apoptosis in human colon carcinoma cells. Asian Pac J Cancer Prev, 13, 6017-22.
20. Feng R, Song Z, Zhai G (2012). Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles. Int J Nanomedicine, 7, 4089-98.
21. Figueiro F, Bernardi A, Frozza RL, et al (2013). Resveratrol-loaded lipid-core nanocapsules treatment reduces in vitro and in vivo glioma growth. J Biomed Nanotechnol, 9, 516-26.
22. Fuertes AB, Valle-Vigon P, Sevilla M (2010). Synthesis of colloidal silica nanoparticles of a tunable mesopore size and their application to the adsorption of biomolecules. J Colloid Interface Sci, 349, 173-80.
23. Gangwar RK, Tomar GB, Dhumale VA, et al (2013). Curcumin Conjugated Silica Nanoparticles for Improving Bioavailability and Its Anticancer Applications. J Agric Food Chem, 61, 9632-7.
24. Gao X, Wang B, Wei X, et al (2012). Anticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancer. Nanoscale, 4, 7021-30.
25. Gao X, Zhang X, Zhang X, et al (2011). Amphiphilic polylactic acid-hyperbranched polyglycerol nanoparticles as a controlled release system for poorly water-soluble drugs: physicochemical characterization. J Pharm Pharmacol, 63, 757-64.
26. Giteau A, Venier-Julienne M-C, Aubert-Pouessel A, Benoit J-P (2008). How to achieve sustained and complete protein release from PLGA-based microparticles? Int J Pharm, 350, 14-26.
27. Gratton SE, Ropp PA, Pohlhaus PD, et al (2008). The effect of particle design on cellular internalization pathways. Proceedings of the National Academy of Sciences, 105, 11613-8.
28. Guri A, Gülseren I, Corredig M (2013). Utilization of solid lipid nanoparticles for enhanced delivery of curcumin in cocultures of HT29-MTX and Caco-2 cells. Food Funct, 4, 1410-9.
29. Guzman-Villanueva D, El-Sherbiny IM, Herrera-Ruiz D, Smyth HD (2013). Design and In vitro evaluation of a new nano- microparticulate system for enhanced aqueous-phase solubility of curcumin. Biomed Res Int, 2013, 724763.
30. Harakeh S, Diab-Assaf M, Azar R, et al (2014). Epigallocatechin-3-gallate Inhibits Tax-dependent Activation of Nuclear Factor Kappa B and of Matrix Metalloproteinase 9 in Human T-cell Lymphotropic Virus-1 Positive Leukemia Cells. Asian Pac J Cancer Prev: APJCP, 15, 1219.
31. He J, Wang X-M, Spector M, Cui F-Z (2012). Scaffolds for central nervous system tissue engineering. Front Mater Sci, 6, 1-25.
32. Hu B, Ting Y, Yang X, et al (2012). Nanochemoprevention by encapsulation of (-)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability. Chem Commun (Camb), 48, 2421-3.
33. Hussain HI, Yi Z, Rookes JE, Kong LX, Cahill DM (2013). Mesoporous silica nanoparticles as a biomolecule delivery vehicle in plants. J Nanopart Res, 15, 1-15.
34. Hussein AS,Abdullah N (2013). In vitro degradation of poly (D, L-lactide-co-glycolide) nanoparticles loaded with linamarin. IET Nanobiotechnol, 7, 33-41.
35. Jain AK, Thanki K, Jain S (2013). Co-encapsulation of tamoxifen and quercetin in polymeric nanoparticles: implications on oral Bioavailability, antitumor efficacy, and drug-Induced toxicity. Molecular Pharmaceutics, 10, 3459-74.
36. Jantas R,Herczynska L (2010). Preparation and characterization of the poly (2-hydroxyethyl methacrylate)-salicylic acid conjugate. Polym Bull, 64, 459-69.
37. Jiang W-j, Wu C-l, Zhang R-r (2012). General assembly of organic molecules in core-shell mesoporous silica nanoparticles. Materials Letters, 77, 100-2.
38. Karthikeyan S, Rajendra Prasad N, Ganamani A, Balamurugan E (2013). Anticancer activity of resveratrol-loaded gelatin nanoparticles on NCI-H460 non-small cell lung cancer cells. Biomedicine&Preventive Nutrition, 3, 64-73.
39. Khan N, Bharali DJ, Adhami VM, et al (2013). Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model. Carcinogenesis, 35, 415-23.
40. Kim MI, Ham HO, Oh S-D, et al (2006). Immobilization of Mucor javanicus lipase on effectively functionalized silica nanoparticles. J Mol Catal B Enzym, 39, 62-8.
41. Kreuter J (2007). Nanoparticles -a historical perspective. Int J Pharm, 331, 1-10.
42. Kulisic-Bilusic T, Schmoller I, Schnabele K, Siracusa L, Ruberto G (2012). The anticarcinogenic potential of essential oil and aqueous infusion from caper (Capparis spinosa L). Food Chemistry, 132, 261-7.
43. Kumar SSD, Surianarayanan M, Vijayaraghavan R, Mandal AB, MacFarlane D (2014). Curcumin loaded poly (2-hydroxyethyl methacrylate) nanoparticles from gelled ionic liquid- In vitro cytotoxicity and anti-cancer activity in SKOV-3 cells. Eur J Pharm Sci, 51, 34-44.
44. Li J-L, Wang L, Liu X-Y, et al (2009). In vitro cancer cell imaging and therapy using transferrin-conjugated gold nanoparticles. Cancer Letters, 274, 319-26.
45. Li Y, Zhang S, Geng J-X, Hu X-Y (2013). Curcumin inhibits human non-small cell lung cancer A549 cell proliferation through regulation of Bcl-2/Bax and cytochrome C. Asian Pac J Cancer Prev, 14, 4599-602.
46. Lin C-H, Cheng S-H, Liao W-N, et al (2012). Mesoporous silica nanoparticles for the improved anticancer efficacy of cis-platin. Int J Pharm, 429, 138-47.
47. Lloyd AW, Faragher RG, Denyer SP (2001). Ocular biomaterials and implants. Biomaterials, 22, 769-85.
48. Ma S, Wang Y, Zhu Y (2011). A simple room temperature synthesis of mesoporous silica nanoparticles for drug storage and pressure pulsed delivery. Journal of Porous Materials, 18, 233-9.
49. Michaud-Levesque J, Bousquet-Gagnon N, Beliveau R (2012). Quercetin abrogates IL-6/STAT3 signaling and inhibits glioblastoma cell line growth and migration. Experimental Cell Research, 318, 925-35.
50. Miladi K, Sfar S, Fessi H, Elaissari A (2013). Drug carriers in osteoporosis: Preparation, drug encapsulation and applications. Int J Pharm, 445, 181-95.
51. Mohanraj V, Chen Y (2006). Nanoparticles-a review. Tropical Journal of Pharmaceutical Research, 5, 561-73.
52. Park SK, Kim KD, Kim HT (2002). Preparation of silica nanoparticles: determination of the optimal synthesis conditions for small and uniform particles. Colloids Surf A Physicochem Eng Asp, 197, 7-17.
53. Pezzuto JM (1997). Plant-derived anticancer agents. Biochem Pharmacol, 53, 121-33.
54. Pool H, Mendoza S, Xiao H, McClements DJ (2013). Encapsulation and release of hydrophobic bioactive components in nanoemulsion-based delivery systems: Impact of physical form on quercetin bioaccessibility. Food Funct, 4, 162-74.
55. Rachmawati H, Edityaningrum CA, Mauludin R (2013). Molecular Inclusion Complex of Curcumin-ß-Cyclodextrin Nanoparticle to Enhance Curcumin Skin Permeability from Hydrophilic Matrix Gel. Aaps Pharmscitech, 14, 1303-12.
56. Rao CR, Kulkarni GU, Thomas PJ, Edwards PP (2000). Metal nanoparticles and their assemblies. Chem Soc Rev, 29, 27-35.
57. Rao KS, El-Hami K, Kodaki T, Matsushige K, Makino K (2005). A novel method for synthesis of silica nanoparticles. J Colloid Interface Sci, 289, 125-31.
58. Ray L, Kumar P, Gupta KC (2013). The activity against Ehrlich's ascites tumors of doxorubicin contained in self assembled, cell receptor targeted nanoparticle with simultaneous oral delivery of the green tea polyphenol epigallocatechin-3-gallate. Biomaterials, 34, 3064-76.
59. Roy M,Mukherjee S (2014). Reversal of Resistance towards Cisplatin by Curcumin in Cervical Cancer Cells. Asian Pac J Cancer Prev: APJCP, 15, 1403.
60. Salehi P, Makhoul G, Roy R, et al (2013). Curcumin loaded NIPAAM/VP/PEG-A nanoparticles: physicochemical and chemopreventive properties. J Biomater Sci Polym Ed, 24, 574-88.
61. Sanna V, Roggio AM, Siliani S, et al (2012). Development of novel cationic chitosan- and anionic alginate-coated poly(D,L-lactide-co-glycolide) nanoparticles for controlled release and light protection of resveratrol. Int J Nanomedicine, 7, 5501-16.
62. Sanna V, Siddiqui IA, Sechi M, Mukhtar H (2013). Resveratrol-Loaded Nanoparticles Based on Poly (epsilon-caprolactone) and Poly(d,l-lactic-co-glycolic acid)-Poly (ethylene glycol) Blend for Prostate Cancer Treatment. Mol Pharm, 10, 3871-81.
63. Sawadogo WR, Schumacher M, Teiten M-H, Dicato M, Diederich M (2012). Traditional West African pharmacopeia, plants and derived compounds for cancer therapy. Biochem Pharmacol, 84, 1225-40.
64. Saxena V,Hussain MD (2013). Polymeric mixed micelles for delivery of curcumin to multidrug resistant ovarian cancer. J Biomed Nanotechnol, 9, 1146-54.
65. Sharma C, Nusri Q-A, Begum S, et al (2012). (-)-Epigallocatechin-3-gallate induces apoptosis and inhibits invasion and migration of human cervical cancer cells. Asian Pac J Cancer Prev: APJCP, 13, 4815-22.
66. Sharma RK, Das S, Maitra A (2005). Enzymes in the cavity of hollow silica nanoparticles. J Colloid Interface Sci, 284, 358-61.
67. Shukla R, Chanda N, Zambre A, et al (2012). Laminin receptor specific therapeutic gold nanoparticles (198AuNP-EGCg) show efficacy in treating prostate cancer. Proc Natl Acad Sci USA, 109, 12426-31.
68. Singh M, Manikandan S, Kumaraguru A (2011). Nanoparticles: A new technology with wide applications. Res J Nanosci Nanotechnol, 1, 1-11.
69. Sjaarda DR, Roach DR, Yagubi AI, Castle AJ, Svircev AM (2013). Role of bacterial exopolysaccharides and monosaccharides in Erwinia amylovora resistance to bacteriophages. Canadian J Plant Pathol, 35, 125.
70. Sobczak-Kupiec A, Malina D, Piatkowski M, et al (2012). Physicochemical and Biological Properties of Hydrogel/Gelatin/Hydroxyapatite PAA/G/HAp/AgNPs Composites Modified with Silver Nanoparticles. J Nanosci Nanotechnol, 12, 9302-11.
71. Sperling R, Parak W (2010). Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles. Philos Trans A Math Phys Eng Sci, 368, 1333-83.
72. Stakleff KS, Sloan T, Blanco D, et al (2012). Resveratrol exerts differential effects in vitro and in vivo against ovarian cancer cells. Asian Pac J Cancer Prev, 13, 1333-40.
73. Stober W, Fink A, Bohn E (1968). Controlled growth of monodisperse silica spheres in the micron size range. J Colloid Interface Sci, 26, 62-9.
74. Sun J, Bi C, Chan HM, et al (2013). Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability. Colloids Surf B Biointerfaces, 111, 367-75.
75. Tang J-C, Shi H-S, Wan L-Q, Wang Y-S, Wei Y-Q (2013). Enhanced antitumor effect of curcumin liposomes with local hyperthermia in the LL/2 model. Asian Pac J Cancer Prev, 14, 2307-10.
76. Tang L,Cheng J (2013). Nonporous silica nanoparticles for nanomedicine application. Nano Today, 8, 290-312.
77. Teiten M-H, Gaascht F, Dicato M, Diederich M (2013). Anticancer bioactivity of compounds from medicinal plants used in European medieval traditions. Biochem Pharmacol. 86, 1239-47.
78. Tsou T-L, Tang S-T, Huang Y-C, et al (2005). Poly (2-hydroxyethyl methacrylate) wound dressing containing ciprofloxacin and its drug release studies. J Mater Sci Mater Med, 16, 95-100.
79. Vanic Z, Skalko-Basnet N (2013). Nanopharmaceuticals for improved topical vaginal therapy: Can they deliver? Eur J Pharm Sci, 50, 29-41.
80. Vergaro V, Lvov YM, Leporatti S (2012). Halloysite Clay Nanotubes for Resveratrol Delivery to Cancer Cells. Macromol Biosci, 12, 1265-71.
81. Wang G, Wang J, Chen X, et al (2013). The JAK2/STAT3 and mitochondrial pathways are essential for quercetin nanoliposome-induced C6 glioma cell death. Cell Death Dis, 4, 746.
82. Wang G, Wang JJ, Yang GY, et al (2012). Effects of quercetin nanoliposomes on C6 glioma cells through induction of type III programmed cell death. Int J Nanomedicine, 7, 271-80.
83. Wu C-F, Yang J-Y, Wang F, Wang X-X (2013a). Resveratrol: botanical origin, pharmacological activity and applications. Chin J Nat Med, 11, 1-15.
84. Wu S, Sun K, Wang X, et al (2013b). Protonation of epigallocatechin-3-gallate (EGCG) results in massive aggregation and reduced oral bioavailability of EGCG-dispersed selenium nanoparticles. J Agric Food Chem, 61, 7268-75.
85. Yang M, Wang G, Yang Z (2008). Synthesis of hollow spheres with mesoporous silica nanoparticles shell. Materials Chemistry and Physics, 111, 5-8.
86. Yin H-T, Tian Q-Z, Guan L, et al (2013a). In vitro and in vivo evaluation of the antitumor efficiency of resveratrol against lung cancer. Asian Pac J Cancer Prev, 14, 1703-6.
87. Yin H-T, Zhang D, Wu X, Huang X-E, Chen G (2013b). In vivo evaluation of curcumin-loaded nanoparticles in a A549 xenograft mice model. Asian Pac J Cancer Prev, 14, 409-12.
88. Zhu J, Marchant RE (2011). Design properties of hydrogel tissue-engineering scaffolds. Expert Rev Med Devices, 8, 607-26.